BOCA RATON, FLORIDA—Arcline Investment Management (“Arcline”), a growth oriented private equity firm with $1.5 billion of capital under management, today announced that it has acquired a majority interest in Akron Biotechnology LLC (“Akron” or “The Company”). Akron will continue to be led by Claudia Zylberberg, PhD, the Company’s founder and CEO and a member of […]

Porvair Sciences announce the new Chromatrap® Homogeniser Spin Column which provides a quick, cost effective way to homogenize cells and tissues lysates in a single step. Developed as a quick, clean and efficient alternative to syringe and needle homogenization techniques – the Chromatrap® Homogeniser Spin Column offers labs an easy-to-use downstream sample processing tool for a […]

Delivers enhanced galactosylation for improved protein quality, and antibody binding and function SANTA ANA, California: FUJIFILM Irvine Scientific, Inc., a world leader in the optimization, development and manufacture of cell culture media and industrial cell culture solutions, today introduced BalanCD Gal Supplement. The new formula has been developed to increase galactosylation in biotherapeutic development, to help achieve […]

Venlo, The Netherlands – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has decided to integrate its global sales resources into its Business Areas (Life Sciences, Molecular Diagnostics and Bioinformatics). This transition is expected to allow the Business Areas to oversee the full value chain from innovation to commercialization, which is expected […]

LA JOLLA, Calif. — The Board of Directors of Cardea Bio and the Board of Directors of Nanosens Innovations have each authorized the respective companies to proceed with a proposed business combination. After the closing, Nanosens would become a subsidiary of Cardea, with the Nanosens brand representing a series of products leveraging the CRISPR-Chip technology. The closing […]

BOULDER, Colo.–Inscripta, Inc., developer of the first benchtop platform for scalable Digital Genome Engineering, today named Jim Lalonde, Ph.D. to its management team. Dr. Lalonde has spent more than 25 years in research and development leadership, overseeing significant advances in methods for enzyme engineering and directed evolution. He will lead strategic business and portfolio development […]

Expansion to include increased royalties and cover additional applications for Company’s technology platform Salt Lake City, Utah –  Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, and LGC, Biosearch Technologies (“LGC”), a global leader in the design, development, and manufacture of sophisticated, custom oligonucleotide-based tools and […]

ANKENY, IA – Proliant Biologicals, LLC (Proliant), an LGI company (Lauridsen Group Inc.), today announced that it has acquired Boval BioSolutions from Lifecycle Biotechnologies of Fort Worth, TX. The acquisition concluded on September 2, 2019 and financial terms of the deal were not disclosed. According to Stephen Welch, President of Proliant, “Boval possesses proprietary technologies […]

Ipswich, MA –2019 sees New England Biolabs (NEB®) celebrate its commitment to advancing next generation sequencing (NGS) technologies through 10 years of innovation in the sample preparation and target enrichment space. For a decade, the NEBNext® portfolio of products has continued to evolve and address challenges associated with library preparation, providing reagents for DNA and RNA […]

IRVINE, Calif. — To help researchers improve data accuracy and cross-study comparisons, Zymo Research is providing complimentary microbiome standards and controls to researchers worldwide through The Microbiomics Standards & Controls Initiative. Because the field of metagenomics has grown rapidly without the use of well-defined controls, data often cannot be replicated from laboratory to laboratory let alone between […]